Boxer Capital Management, LLC - 06 Nov 2024 Form 4 Insider Report for Tango Therapeutics, Inc. (TNGX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
07 Nov 2024, 21:30:23 UTC
Prior SEC filing
28 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aaron I. Davis, Managing Member, Boxer Capital Management, LLC

Key filing fact

Boxer Capital Management, LLC filed Form 4 for Tango Therapeutics, Inc. (TNGX) on 07 Nov 2024.

Key facts

  • This page summarizes Boxer Capital Management, LLC's Form 4 filing for Tango Therapeutics, Inc. (TNGX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Nov 2024, 21:30.

Change

  • Previous filing in this sequence was filed on 28 Oct 2024.
  • Current net transaction value: -$9,671,200.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNGX transaction

Common Stock

Sale

Transaction value
$9,671,200
Shares
-3,080,000
Change %
-46%
Price
$3.14
Shares after
3,610,642
Date
06 Nov 2024
Ownership
See footnote
Footnotes
F1, F2
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
108,793
Date
06 Nov 2024
Ownership
See footnote
Footnotes
F3
TNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,988,450
Date
06 Nov 2024
Ownership
See footnote
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Boxer Capital Management, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.3955, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

These securities are held indirectly by Boxer Capital Management, LLC ("BCM") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any.

Footnote F3

These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors, but disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any. BCM disclaims beneficial ownership of these securities.

Footnote F4

These securities are owned directly by BCTG Holdings, LLC ("BCTG"). MVA Investors is a member of BCTG. Mr. Davis is a member of the investment committee of BCTG. Mr. Davis disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. BCM disclaims beneficial ownership of these securities.

SEC remarks

The Reporting Persons may be deemed members of a group that formerly beneficially owned more than 10% of the outstanding shares of the Issuer's Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .